Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

383 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Feasibility of newly designed rotatable sphincterotome for endoscopic sphincterotomy (with video).
Hori Y, Hayashi K, Naitoh I, Okumura F, Anbe K, Miyabe K, Hirano A, Takada H, Jinno N, Yoshida M, Kato A, Kachi K, Sahashi H, Adachi A, Toyohara T, Kuno K, Kito Y, Kataoka H. Hori Y, et al. Among authors: kito y. Endosc Int Open. 2024 Nov 28;12(11):E1374-E1378. doi: 10.1055/a-2422-2425. eCollection 2024 Nov. Endosc Int Open. 2024. PMID: 39610948 Free PMC article.
Real-world treatment costs of first-line treatment for metastatic colorectal cancer: a survey of the JCOG colorectal cancer study group.
Takashima A, Ishiguro M, Sasaki K, Machida R, Nagashima F, Imaizumi J, Hamaguchi T, Yamamoto Y, Masuishi T, Asayama M, Ueno H, Shinozaki K, Kudo T, Machida N, Matsuoka H, Ishida H, Yamaguchi T, Nogami H, Yamada T, Takegawa N, Kito Y, Tonoike Y, Sawada R, Tsukamoto S, Kanemitsu Y; Colorectal Cancer Study Group (CCSG) of the Japan Clinical Oncology Group (JCOG). Takashima A, et al. Among authors: kito y. Jpn J Clin Oncol. 2024 Oct 3;54(10):1107-1114. doi: 10.1093/jjco/hyae110. Jpn J Clin Oncol. 2024. PMID: 39210583
Real-world outcomes of FOLFOXIRI plus bevacizumab in patients with metastatic colorectal cancer: the JSCCR-TRIPON study.
Yamamoto Y, Yukami H, Yamaguchi T, Ohori H, Nagasu S, Kagawa Y, Sugimoto N, Sonoda H, Yamazaki K, Takashima A, Okuyama H, Hasegawa H, Kondo C, Baba E, Matsumoto T, Kawamoto Y, Kataoka M, Shindo Y, Ishikawa T, Esaki T, Kito Y, Sato T, Funakoshi T, Yamaguchi T, Shimada Y, Moriwaki T. Yamamoto Y, et al. Among authors: kito y. Int J Clin Oncol. 2024 Dec;29(12):1878-1886. doi: 10.1007/s10147-024-02613-0. Epub 2024 Aug 28. Int J Clin Oncol. 2024. PMID: 39196470
Distinct Perception Mechanisms of BACH1 Quaternary Structure Degrons by Two F-box Proteins under Oxidative Stress.
Cao S, Shi H, Garcia SF, Kito Y, Shi H, Goldberg HV, Ponce J, Ueberheide B, Lignitto L, Pagano M, Zheng N. Cao S, et al. Among authors: kito y. bioRxiv [Preprint]. 2024 Jun 3:2024.06.03.594717. doi: 10.1101/2024.06.03.594717. bioRxiv. 2024. Update in: Cell. 2024 Oct 30:S0092-8674(24)01188-7. doi: 10.1016/j.cell.2024.10.012 PMID: 38895309 Free PMC article. Updated. Preprint.
Discrepancy in the Location of Prostate Cancer Indicated on Biparametric Magnetic Resonance Imaging and Pathologically Diagnosed Using Surgical Specimens.
Tomioka M, Nakane K, Kawase M, Iinuma K, Kato D, Kawase K, Taniguchi T, Tobisawa Y, Sugino F, Kaga T, Kato H, Matsuo M, Kito Y, Saigo C, Suzui N, Ito T, Miyazaki T, Takeuchi T, Koie T. Tomioka M, et al. Among authors: kito y. Curr Oncol. 2024 May 16;31(5):2846-2855. doi: 10.3390/curroncol31050216. Curr Oncol. 2024. PMID: 38785497 Free PMC article.
Tumor Response Predicts Survival Time of Nivolumab Monotherapy for Advanced Gastric Cancer: A Subgroup Analysis of the DELIVER Trial (JACCRO GC-08).
Sunakawa Y, Sakamoto Y, Kawabata R, Ishiguro A, Akamaru Y, Kito Y, Takahashi M, Matsuyama J, Yabusaki H, Makiyama A, Suzuki T, Tsuda M, Yasui H, Hihara J, Takeno A, Inoue E, Ichikawa W, Fujii M. Sunakawa Y, et al. Among authors: kito y. Oncologist. 2024 Aug 5;29(8):e997-e1002. doi: 10.1093/oncolo/oyae056. Oncologist. 2024. PMID: 38581687 Free PMC article.
CA125 Kinetics as a Potential Biomarker for Peritoneal Metastasis Progression following Taxane-Plus-Ramucirumab Administration in Patients with Advanced Gastric Cancer.
Ueda A, Yuki S, Ando T, Hosokawa A, Nakada N, Kito Y, Motoo I, Ito K, Sakumura M, Nakayama Y, Ueda Y, Kajiura S, Nakashima K, Harada K, Kawamoto Y, Komatsu Y, Yasuda I. Ueda A, et al. Among authors: kito y. Cancers (Basel). 2024 Feb 22;16(5):871. doi: 10.3390/cancers16050871. Cancers (Basel). 2024. PMID: 38473233 Free PMC article.
383 results